Why does null hypothesis testing matter for MRgHIFU drug release?

Null hypothesis testing ensures that observed increases in intratumoral drug levels are attributable to MRgHIFU-induced hyperthermia rather than confounding variables, supporting robust target validation and mechanistic clarity in preclinical studies.

How does independent variable isolation fit the hyperthermia protocol?

The protocol isolates hyperthermia as the independent variable by controlling temperature within the tumor region, enabling clear attribution of drug release and immune effects to the intervention and informing discovery-stage decision points.

What do quantitative dependent variable measurements enable in this workflow?

Quantitative measurements, such as HPLC-MS analysis of doxorubicin accumulation, enable precise comparison of drug delivery efficiency and pharmacokinetics across treatment conditions, supporting data-driven advancement decisions.

Why are replication requirements critical for cross-functional collaboration?

Replication of hyperthermia and drug release outcomes ensures reproducibility across teams, facilitating standardized data generation and reliable cross-functional interpretation for portfolio triage and translational planning.

What statistical analysis capabilities are required before implementation?

Robust statistical analysis, including comparison of drug accumulation and treatment success rates, is essential to validate protocol performance and inform go/no-go criteria for further preclinical or translational studies.

Manyetik Rezonans Rehberliğinde Yüksek Yoğunluklu Odaklanmış Ultrason Tarafından Üretilen Hipertermi: Bir Murin Rabdomiyosarkom Modelinde Uygulanabilir Bir Tedavi Yöntemi

2.6K views

Cited by 3

13:41 min

January 13th, 2023

10.3791/64544-v

January 13th, 2023

2.6K views

Claire Wunker¹^,² , Karolina Piorkowska³ , Ben Keunen³ , Yael Babichev² , Suzanne M. Wong³^,⁴ , Maximilian Regenold⁵ , Michael Dunne⁵ , Julia Nomikos¹^,² , Maryam Siddiqui⁶ , Samuel Pichardo⁶ , Warren Foltz⁷ , Adam C. Waspe³^,⁸ , Justin T. Gerstle³^,⁹ , James M. Drake¹^,³^,⁴^,¹⁰ , Rebecca A. Gladdy¹^,²^,¹⁰

¹Institute of Medical Science, University of Toronto, ²Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, ³The Wilfred and Joyce Posluns Centre for Image-Guided Innovation and Therapeutic Intervention, The Hospital for Sick Children, ⁴Institute of Biomedical Engineering, University of Toronto, ⁵Leslie Dan Faculty of Pharmacy, University of Toronto, ⁶Departments of Radiology and Clinical Neurosciences, University of Calgary, ⁷Department of Radiation Oncology, University of Toronto, ⁸Department of Medical Imaging, University of Toronto, ⁹Department of Pediatric Surgery, University of Toronto, ¹⁰Department of Surgery, University of Toronto

Burada, rabdomiyosarkom fare modelinde sıcaklığa duyarlı lipozomlardan ilaç salınımını tetiklemek için manyetik rezonans rehberliğinde yüksek yoğunluklu odaklanmış ultrason tarafından üretilen kontrollü hipertermiyi kullanmak için bir protokol sunulmaktadır.